advertisement
Lämmer R 78
Showing records 1 to 25 | Display only abstracts from Lämmer R in IGR 25-1122479 Glaucoma detection using non-perfused areas in OCTA
Schottenhamml J; Würfl T; Ploner S; Husvogt L; Lämmer R; Hohberger B; Maier A; Mardin C
Scientific reports 2024; 14: 10306 (IGR: 25-1)
116847 Pattern electroretinogram, blue-yellow visual evoked potentials and the risk of developing visual field defects in glaucoma suspects: a longitudinal "survival" analysis with a very long follow-up
Huchzermeyer C
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1607-1618 (IGR: 24-4)
117276 Improving Glaucoma Patients' Quality of Life and Adherence With a Digital Health Application: RETRACTED
Blanke L; Zinsmeister L
Journal of Glaucoma 2023; 0: (IGR: 24-4)
116847 Pattern electroretinogram, blue-yellow visual evoked potentials and the risk of developing visual field defects in glaucoma suspects: a longitudinal "survival" analysis with a very long follow-up
Lämmer R
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1607-1618 (IGR: 24-4)
117276 Improving Glaucoma Patients' Quality of Life and Adherence With a Digital Health Application: RETRACTED
Schnell S
Journal of Glaucoma 2023; 0: (IGR: 24-4)
116847 Pattern electroretinogram, blue-yellow visual evoked potentials and the risk of developing visual field defects in glaucoma suspects: a longitudinal "survival" analysis with a very long follow-up
Mardin CY
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1607-1618 (IGR: 24-4)
117276 Improving Glaucoma Patients' Quality of Life and Adherence With a Digital Health Application: RETRACTED
Steinhorst K
Journal of Glaucoma 2023; 0: (IGR: 24-4)
116847 Pattern electroretinogram, blue-yellow visual evoked potentials and the risk of developing visual field defects in glaucoma suspects: a longitudinal "survival" analysis with a very long follow-up
Kruse FE
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1607-1618 (IGR: 24-4)
117276 Improving Glaucoma Patients' Quality of Life and Adherence With a Digital Health Application: RETRACTED
Lämmer R
Journal of Glaucoma 2023; 0: (IGR: 24-4)
116847 Pattern electroretinogram, blue-yellow visual evoked potentials and the risk of developing visual field defects in glaucoma suspects: a longitudinal "survival" analysis with a very long follow-up
Kremers J; Horn FK
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1607-1618 (IGR: 24-4)
117276 Improving Glaucoma Patients' Quality of Life and Adherence With a Digital Health Application: RETRACTED
Michelson G
Journal of Glaucoma 2023; 0: (IGR: 24-4)
109370 The influence of trace elements on the therapeutic success of suprachoroidal draining devices
Wörn M; Lämmer R; Lucio M; Michalke B; Rühl E; Hohberger B
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) 2023; 78: 127195 (IGR: 24-1/2)
105970 Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance
Hohberger B; Prüss H; Mardin C; Lämmer R; Müller J; Wallukat G
PLoS ONE 2022; 17: e0272811 (IGR: 23-3)
104585 Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation
Szewczykowski C; Mardin C; Lucio M; Wallukat G; Hoffmanns J; Schröder T; Raith F; Rogge L; Heltmann F; Moritz M; Beitlich L; Schottenhamml J; Herrmann M; Harrer T; Ganslmayer M; Kruse FE; Kräter M; Guck J; Lämmer R; Zenkel M; Gießl A; Hohberger B
International journal of molecular sciences 2022; 23: (IGR: 23-2)
99057 Ultrastructural analysis of explanted CyPass microstents and correlation with clinical findings
Hübner L; Schlötzer-Schrehardt U; Weller JM; Hohberger B; Mardin CY; Lämmer R
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 2663-2673 (IGR: 22-4)
96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Hohberger B
Frontiers in medicine 2021; 8: 754667 (IGR: 22-3)
95970 Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Dussan Molinos L
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 1171-1181 (IGR: 22-3)
96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Hohberger B
Frontiers in neuroscience 2021; 15: 676579 (IGR: 22-3)
96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Harrer T
Frontiers in medicine 2021; 8: 754667 (IGR: 22-3)
96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Schlötzer-Schrehard U
Frontiers in neuroscience 2021; 15: 676579 (IGR: 22-3)
95970 Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Huchzermeyer C
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 1171-1181 (IGR: 22-3)
96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Mardin C
Frontiers in neuroscience 2021; 15: 676579 (IGR: 22-3)
95970 Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Lämmer R
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 1171-1181 (IGR: 22-3)
96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Mardin C
Frontiers in medicine 2021; 8: 754667 (IGR: 22-3)
95970 Blue-Yellow VEP with Projector-Stimulation in Glaucoma
Kremers J
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 1171-1181 (IGR: 22-3)
